Who owns AZN
1,327 institutions reported holding AZN for 2026Q1, together 48% of the company, fewer than the 1,374 a quarter earlier.
1,327
Institutions reporting a position · as of 2026Q1 · down from 1,374 the quarter before
- Shares held by institutions
- 746.4M
Shares held by institutions · 48% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $149.5B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 14%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 52
- New positions
- 270
- Positions exited
- 323
- Added to
- 107
- Reduced
- 936
- Top 10 holdersof the company
- 21%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 1,327 | 746.4M | $149.5B |
| 2025Q4 | 1,374 | 487.5M | $44.8B |
| 2025Q3 | 1,259 | 492.1M | $37.8B |
| 2025Q2 | 1,194 | 494.2M | $34.6B |
| 2025Q1 | 1,219 | 500.5M | $37.3B |
| 2024Q4 | 1,189 | 512.4M | $33.6B |
| 2024Q3 | 1,215 | 490.9M | $38.3B |
| 2024Q2 | 1,197 | 498.3M | $38.9B |
| 2024Q1 | 1,122 | 490.0M | $33.2B |
| 2023Q4 | 1,115 | 490.7M | $33.1B |
| 2023Q3 | 1,061 | 495.8M | $33.6B |
| 2023Q2 | 1,076 | 490.3M | $36.1B |
| 2023Q1 | 1,036 | 506.3M | $34.9B |
| 2022Q4 | 1,043 | 509.4M | $34.1B |
| 2022Q3 | 950 | 512.6M | $28.1B |
| 2022Q2 | 999 | 526.5M | $34.8B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| VANGUARD GROUP INC | 78.1M | 5.0% | $15.3B |
| INVESTOR AB | 51.6M | 3.3% | $10.2B |
| Capital International Investors | 34.4M | 2.2% | $6.72B |
| FMR LLC | 29.6M | 1.9% | $5.80B |
| Capital World Investors | 28.3M | 1.8% | $5.52B |
| Legal & General Group Plc | 25.8M | 1.7% | $5.01B |
| WELLINGTON MANAGEMENT GROUP LLP | 23.8M | 1.5% | $4.63B |
| PRICE T ROWE ASSOCIATES INC /MD/ | 19.5M | 1.3% | $3.84B |
| BANK OF AMERICA CORP /DE/ | 19.1M | 1.2% | $3.76B |
| JPMORGAN CHASE & CO | 18.6M | 1.2% | $3.60B |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Drug Manufacturers - General
Ranks #3 of 16 by Smart Score